Pattern of care for advanced non-small cell lung cancer in the era of histology-based treatment: A survey of the Italian Association of Thoracic Oncology (AIOT)

Lung Cancer

Volumn 67, Issue 3, 2010, Pages 339-342

  Gridelli, Cesare ^a   Rossi, Antonio ^a   de Marinis, Filippo ^b  

^a S G MOSCATI HOSPITAL   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Advanced NSCLC; Elderly patients; PS 2; Second line; Survey

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CISPLATIN; DOCETAXEL; ERLOTINIB; GEMCITABINE; NAVELBINE; PACLITAXEL; PEMETREXED; PLATINUM COMPLEX;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG CHOICE; ELDERLY CARE; HEALTH CARE QUALITY; HEALTH STATUS; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; ITALY; LUNG NON SMALL CELL CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE;

CARCINOMA, NON-SMALL-CELL LUNG; GUIDELINE ADHERENCE; HUMANS; ITALY; LUNG NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES;

EID: 75749112866     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.04.023     Document Type: Article

References (14)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics 2002. CA Cancer J Clin 55 (2005) 74-108
2. Govindan R., Page N., Morgensztern D., Read W., Tierney R., Vlahiotis A., et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 24 (2006) 4539-4544
3. Schiller J.H., Harrington D., Belani C.P., Langer C., Sandler A., Krook J., et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346 (2002) 92-98
4. Scagliotti G.V., Parikh P., von Pawel J., Biesma B., Vansteenkiste J., Manegold C., et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26 (2008) 3543-3551
5. Sandler A., Gray R., Perry M.C., Brahmer J., Schiller J.H., Dowlati A., et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small cell lung cancer. N Engl J Med 355 (2006) 2542-2550
6. Manegold C., von Pawel J., Zatloukal P., Ramlau R., Gorbounova V., Hirsh V., et al. BO17704 (AVAIL): a phase II randomised study of first-line bevacizumab combined with cisplatin/gemcitabine (CG) in patients (PTS) with advanced or recurrent non-squamous, non-small cell lung cancer (NSCLC). Ann Oncol 19 Suppl. 8 (2008) viii1 (abstr. LBA1)
7. Pirker R., Pereira J.R., Szczesna A., von Pawel J., Krzakowski M., Ramlau R., et al. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open label randomised phase III trial. Lancet 373 (2009) 1525-1531
8. Gridelli C., Aapro M., Ardizzoni A., Balducci L., De Marinis F., Kelly K., et al. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel. J Clin Oncol 23 (2005) 3125-3137
9. Gridelli C., Ardizzoni A., Le Chevalier T., Manegold C., Perrone F., Thatcher N., et al. Treatment of advanced non small cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel. Ann Oncol 15 (2004) 419-426
10. Gridelli C., Ardizzoni A., Ciardiello F., Hanna N., Heymach J.V., Perrone F., et al. Second-line treatment of advanced non-small cell lung cancer. J Thorac Oncol 3 (2008) 430-440
11. Peterson P., Park K., Fossella F., Gatzemeier U., John W., and Scagliotti G. Is pemetrexed more effective in adenocarcinoma and large cell lung cancer than in squamous cell carcinoma?. J Thorac Oncol 2 Suppl. 4 (2007) S851 (abstr. P2-238)
12. Ciuleanu T.E., Brodowicz T., Belani C.P., Kim J., Krzakowski M., Laack E., et al. Maintenance pemetrexed plus best supportive care (BSC) versus placebo plus BSC: a phase III study. J Clin Oncol 26 15S (2008) 426s (abstr. 8011)
13. Soon Y., Stockler M.R., Boyer M., and Askie L. Duration of chemotherapy for advanced non-small cell lung cancer: an updated systematic review and meta-analysis. J Clin Oncol 26 15S (2008) 427s (abstr. 8013)
14. Gridelli C., Rossi A., Maione P., Colantuoni G., Del Gaizo F., Ferrara C., et al. Erlotinib in non-small cell lung cancer. Exp Opin Pharmacother 8 (2007) 2579-2592